argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients Biotech Investing
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing Life Science Investing
Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer's Disease Neuroimaging Initiative Control Group Life Science Investing
Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy Life Science Investing
Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 Life Science Investing
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635 Life Science Investing
